Dr. Michael Morse
Hematology & Oncology · Durham, NC
CMS Profile ID: 1262085 · NPI: 1588748479
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$490,289
Number of Payments
380
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $308,638 |
| Compensation for serving as faculty or as a speaker for a medical education program | $82,988 |
| Travel and Lodging | $58,659 |
| Consulting Fee | $30,400 |
| Food and Beverage | $6,305 |
| Honoraria | $3,300 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Ipsen Biopharmaceuticals, Inc | $95,099 |
| TAIHO ONCOLOGY, INC. | $91,457 |
| AstraZeneca Pharmaceuticals LP | $90,381 |
| Eisai Inc. | $62,476 |
| JAZZ PHARMACEUTICALS INC. | $56,829 |
| Incyte Corporation | $40,248 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?